Nódulos Eritematosos Suprapúbicos numa Doente Idosa
Resumo
.
Downloads
Referências
Fujii K, Hamada T, Shimauchi T, Asai J, Fujisawa Y, Ihn H, et al. Cutaneous lymphoma in Japan, 2012-2017: A nationwide study. J Dermatol Sci. 2020; 97:187-93. doi: 10.1016/j.jdermsci.2020.01.010.
Lee WJ, Won KH, Won CH, Chang SE, Choi JH, Moon KC, et al. Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage. Br J Dermatol. 2015; 173:134-45. doi: 10.1111/bjd.13582.
Kaddis N, Fisher D, Jacobsen ED. Cutaneous Involvement of Hematologic Malignancies. Hematol Oncol Clin North Am. 2019; 33:163-72. doi: 10.1016/j.hoc.2018.08.005.
Yasukawa K, Kato N, Kodama K, Hamasaka A, Hata H. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification. J Cutan Pathol. 2006; 33:487-91. doi: 10.1111/j.1600-0560.2006.00460.x.
Lee WJ, Won KH, Won CH, Chang SE, Choi JH, Moon KC, et al. Secondary cutaneous diffuse large B-cell lymphoma has a higher international prognostic index score and worse prognosis than diffuse large B-cell lymphoma, leg type. Acta Derm Venereol. 2016;96:245-50. doi: 10.2340/00015555-2139.
Ferrão JB, Barreira JV, Marote S, Parmanande A. Diffuse large B cell lymphoma: cutaneous presentation. BMJ Case Rep. 2018;11:e226839. doi: 10.1136/bcr-2018-226839.
Direitos de Autor (c) 2020 Revista da Sociedade Portuguesa de Dermatologia e Venereologia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Todos os artigos desta revista são de acesso aberto sob a licença internacional Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0).
